60 likes | 66 Views
The active implantable medical devices are adopted in diagnostic and therapeutic applications and they are implanted in patient's body fully or partially. The COVID-19 pandemic has had an adverse impact on the global active implantable medical device industry owing to disruption on the supply chain and hospitals prioritizing COVID-19 patients and all other treatments are canceled or postponed, resulting in slow down of the implantable medical devices market.
E N D
About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.
Global Active Implantable Medical Device Market The global active implantable medical device market will grow at 7.1% CAGR owing to the rising incidences of cardiovascular and neurological diseases, increased investment in technologically developed products, effortless operative procedures, rising geriatric population, The active implantable medical devices are adopted in diagnostic and therapeutic applications and they are implanted in patient's body fully or partially. The COVID-19 pandemic has had an adverse impact on the global active implantable medical device industry owing to disruption on the supply chain and hospitals prioritizing COVID-19 patients and all other treatments are canceled or postponed, resulting in slow down of the implantable medical devices market.
Global Active Implantable Medical Device Market Based on the product, the implantable cardioverter defibrillators segment contributes to the largest share of the active implantable medical devices market due to the rising cases of cardiovascular diseases, technologically advanced devices, and rising demand for these devices in emerging economies. The neurostimulators holds a significant share due to the rising incidences of chronic pain like neuropathic pain, pain occurring due to diabetes, arthritis, anxiety, thereby increasing the demand for neurostimulators. North America dominates the active implantable medical devices market owing to the rising geriatric population, increasing cases of cardiovascular and neurological diseases, high obesity rates, high accessibility to developed technologies, and increasing healthcare expenditure in the region. However, Asia-Pacific is expected to witness the fastest growth during the forecast period owing to the growth in geriatric population, rising incidence of chronic diseases, rising healthcare spending, the establishment of healthcare infrastructure, growing demand for developing technologies to innovate advanced products, and less strict regulations.
Global Active Implantable Medical Device Market Medtronic plc has developed Attain Stability Quad MRI SureScan for active fixation of left heart lead that is paired with pacemakers and defibrillators for quadripolar cardiac resynchronization therapy. The prominent players in the active implantable medical devices industry include Abbott Laboratories, Boston Scientific Corporation, Nurotron Biotechnology Co. Ltd, Medtronic PLC, Med-EL, Biotronik Se & Co., Kg, Sonova Holding AG, Cochlear Limited, William Demant Holding A/S, and Livanova PLC.
For Sample Report :- https://www.vynzresearch.com/healthcare/active-implantable-medical-device-market/request-sample www.vynzresearch.com